Prescription drug · NDA
Yuviwel (Navepegritide) NDC 73362-201
Kit · Ascendis Pharma Endocrinology, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73362-201-01 | 73362020101 | 4 BOX in 1 CARTON (73362-201-01) / 1 KIT in 1 BOX (73362-201-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (73362-205-01) * 1 SOLUTION in 1 SYRINGE, GLASS (73362-801-01)Marketed from Feb 27, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Yuviwel
- Generic name (nonproprietary)
- navepegritide
- Dosage form
- Kit
- Labeler
- Ascendis Pharma Endocrinology, Inc.NDC labeler code 73362
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 219164
- Marketing start
- Listing expires
- Identifiers
- Product ID 73362-201_7bc0f18a-5736-4451-8790-f3780b742ab3SPL ID 7bc0f18a-5736-4451-8790-f3780b742ab3SPL set ID e01c1197-338f-414c-b804-808e129ebc8cRxCUI 2739524, 2739529, 2739531, 2739533, 2739535, 2739537
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N473362020101followed by a unit qualifier and the quantityPackage 73362-0201-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
YUVIWEL ® is indicated to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses. This indication is approved under accelerated approval based on an improvement in annualized growth velocity [see Clinical Studies (14) ]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s). YUVIWEL is a C-type natriuretic peptide (CNP) analog indicated to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses. ( 1 ) This indication is approved under accelerated approval based on an improvement in annualized growth velo…
Excerpt only. Read the full label for complete information.
About NDC 73362-201
- What is NDC 73362-201?
- 73362-201 is the product NDC for Yuviwel (navepegritide) kit, listed with the FDA by Ascendis Pharma Endocrinology, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Yuviwel (Navepegritide).
- Who is the labeler?
- Ascendis Pharma Endocrinology, Inc., NDC labeler code 73362. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Yuviwel?
- 2 other product NDCs are listed under this name. See all Yuviwel NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Yuviwel products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Yuviwelnavepegritide | — | Kit | Ascendis Pharma Endocrinology, Inc. | 73362-202 | 73362-0202-01 |
| Yuviwelnavepegritide | — | Kit | Ascendis Pharma Endocrinology, Inc. | 73362-203 | 73362-0203-01 |
Other NDCs under NDA 219164
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Yuviwelnavepegritide | — | Kit | Ascendis Pharma Endocrinology, Inc. | 73362-202 |
| Yuviwelnavepegritide | — | Kit | Ascendis Pharma Endocrinology, Inc. | 73362-203 |